O/m items only: biological materials, chemicals, medical/scientific equipment/instruments, medical/scientific/equipment maintenance repair

Active Blanket Purchase Agreement Awarded Last action

Contract number
75N98024A00046
Awardee
Awarding agency
Task orders
4 $52,931 obligated

Award facts

Combined order value
  • $52,931 Current, with exercised options
  • $65,407 Potential, with all options
Last date to order 93% complete
IDV ceiling 1% used
$10,000,000.00
Maximum order
$25,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

Promega Corporation, a large for-profit life sciences manufacturer headquartered in Madison, Wisconsin, was awarded a $10 million single-award Blanket Purchase Agreement by the National Institutes of Health's Office of Logistics and Acquisition Operations on December 31, 2023, with a completion date of December 31, 2026. The BPA covers the procurement of biological materials, chemicals, medical and scientific equipment, instruments, and maintenance repair services to support research and testing operations across multiple NIH institutes and centers. No small business set-aside was applied to this award, reflecting Promega's status as a large business capable of meeting complex federal research requirements. Promega performs work from multiple locations, including its headquarters in Madison, Wisconsin, and facilities in Bethesda, Maryland, positioning the company to efficiently deliver specialized laboratory products and services.

Since the BPA's award date, Promega has received multiple firm fixed-price task orders under this indefinite delivery vehicle totaling approximately $65,406.50 across several NIH components. Task orders executed by the National Center for Advancing Translational Sciences include the HIBIT-tagged IRAK1 cell line ($12,103, completed September 21, 2026), the IRAK4-HIBIT KI NCI-H1299 CPM cell line ($12,103, completed September 17, 2026), and the CASPASE-GLO 3/7 Assay ($22,486.80, completed March 8, 2024). The National Cancer Institute issued a service agreement call valued at $18,713.70 with performance extending through January 31, 2027. These task orders demonstrate Promega's delivery of advanced molecular diagnostic tools, specialized cell lines for biomedical research, and assay kits that support the NIH's translational research and cancer research missions across civilian federal agencies.

Task orders

Task order Ordering agency Obligated Awarded
Hibit-tagged IRAK1 cell line 75N95C25F00002 National Center for Advancing Translational Sciences (NIH) $12,103
IRAK4-hibit KI NCI-H1299 CPM - cell line 75N95C25F00001 National Center for Advancing Translational Sciences (NIH) $12,103
Caspase-GLO(r) 3/7 assay 75N95024F00001 National Institute on Drug Abuse (NIH) $22,487
Service agreement 75N91024F00001 National Cancer Institute (NIH) $6,238

Transactions

Action Obligated Date
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N98024A00046?

75N98024A00046 was awarded to Promega Corporation by Office of Logisitics and Acquisition Operations (National Institutes of Health) on December 31, 2023.

How much is contract 75N98024A00046 worth?

Orders under 75N98024A00046 have obligated $52,931. Their combined potential value, with all options, is $65,407. 75N98024A00046's own ceiling is $10,000,000. A single order can be worth up to $25,000.

How many orders have been placed under contract 75N98024A00046?

4 orders have been placed under 75N98024A00046, the latest on September 22, 2025.

Who can order from contract 75N98024A00046?

75N98024A00046 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV